|
|
CTD Chemicals (CC): Cyclohexenes 
(show info)
Biomedical Ontology
Like Gene Ontology (GO), biomedical ontology such as phenotype ontology classifies and organizes gene-mutant/null phenotypic information from the very general at the top to more specific terms in the directed acyclic graph (DAG) by viewing an individual term as a node and its relations to parental terms (allowing for multiple parents) as directed edges. To navigate this hierarchy, we display all parental phenotypic terms to the current phenotypic term of interest ordered by their shortest distances to the current term. Also, only direct children phenotypic terms of the current phenotypic term are listed. Biomedical ontologies we have incorporated are as follows:
- Disease Ontology (DO) Ontology DO semantically integrates disease and medical vocabularies through extensive cross mapping of DO terms to MeSH, ICD, NCI’s thesaurus, SNOMED and OMIM.
- Human Phenotype (HP) Ontology HP captures phenotypic abnormalities that are described in OMIM, along with the corresponding disease-causing genes. It includes three complementary biological concepts: Mode_of_Inheritance (MI), ONset_and_clinical_course (ON), and Phenotypic_Abnormality (PA).
- Mouse Phenotype (MP) Ontology MP describes phenotypes of the mouse after a specific gene is genetically disrupted. Using it, Mouse Genome Informatics (MGI) provides high-coverate gene-level phenotypes for the mouse.
- Worm Phenotype (WP) Ontology WP classifies and organizes phenotype descriptions for C. elegans and other nematodes. Using it, WormBase provides primary resource for phenotype annotations for C. elegans.
- Yeast Phenotype (YP) Ontology Based on YP which is the major contributor to the ‘Ascomycete phenotype ontology’, Saccharomyces Genome Database (SGD) provides single mutant phenotypes for every gene in the yeast genome.
- Fly Phenotype (FP) Ontology FP refers to FlyBase controlled vocabulary. Specifically, a structured controlled vocabulary is used for the annotation of alleles (for their mutagen etc) in FlyBase.
- Fly Anatomy (FA) Ontology FA is a structured controlled vocabulary of the anatomy of Drosophila melanogaster, used for the description of phenotypes and where a gene is expressed.
- Zebrafish Anatomy (ZA) Ontology ZA displays anatomical terms of the zebrafish using standard anatomical nomenclature, together with affected genes.
- Xenopus Anatomy (XA) Ontology XA represents the lineage of tissues and the timing of development for frogs (Xenopus laevis and Xenopus tropicalis). It is used to annotate Xenopus gene expression patterns and mutant and morphant phenotypes.
- Arabidopsis Plant Ontology (AP) Ontology As a major contributor to Plant Ontology which describes plant anatomical and morphological structures (AN) and growth and developmental stages (DE), the Arabidopsis Information Resource (TAIR) provides arabidopsis plant ontology annotations for the model higher plant Arabidopsis thaliana.
- Enzyme Commission (EC) Ontology Each enzyme is allocated a four-digit EC number, the first three digits of which define the reaction catalysed and the fourth of which is a unique identifier (serial number). Each enzyme is also assigned a systematic name that uniquely defines the reaction catalysed.
- UniProtKB KeyWords (KW) Ontology Keywords in UniProtKB are controlled vocabulary, providing a summary of the entry content and are used to index UniProtKB/Swiss-Prot entries based on 10 categories (the category "Technical term" being excluded here). Each keyword is attributed manually to UniProtKB/Swiss-Prot entries and automatically to UniProtKB/TrEMBL entries (according to specific annotation rules).
- CTD Diseases (CD) Ontology CD is MEDIC disease vocabulary that is modified by CTD from the "Diseases" [C] branch of Medical Subject Headings (MeSH), combined with genetic disorders from the Online Mendelian Inheritance in OMIM database.
- CTD Chemicals (CC) Ontology CC is chemical vocabulary that is adapted by CTD from the "Chemicals and Drugs" category and Supplementary Concept Records of Medical Subject Headings (MeSH, a hierarchical vocabulary used to index articles for MEDLINE/PubMed).
Jump to [ Top · Hierarchy · Annotations ]
Root: CC Hierarchy (CTD chemicals from Comparative Toxicogenomics Database)
| Shortest distance to current term (+ for parents, - for children) |
CC term [CC ID] <#Children> |
#Domains (Superfamily|Family) |
#Supra-domain (Single|Duplex|Triple) |
| + + + + + + + 7: | Chemicals [MESH:D] <13> |
| + + + + + + 6: | Organic Chemicals [MESH:D009930] <621> | (617|829) |
(620|532|254) |
| + + + + + 5: | Hydrocarbons [MESH:D006838] <35> | (468|641) |
(485|436|221) |
| + + + + 4: | Polycyclic Compounds [MESH:D011083] <191> | (419|579) |
(431|390|204) |
| + + + + 4: | Hydrocarbons, Cyclic [MESH:D006844] <11> | (425|591) |
(443|416|217) |
| + + + 3: | Hydrocarbons, Alicyclic [MESH:D006840] <3> | (114|125) |
(121|74|36) |
| + + + 3: | Macrocyclic Compounds [MESH:D047028] <111> | (186|253) |
(192|153|75) |
| + + 2: | Cycloparaffins [MESH:D003516] <36> | (113|125) |
(120|74|36) |
| + 1: | Cyclohexanes [MESH:D003510] <320> | (90|101) |
(94|54|24) |
| 0: | Cyclohexenes [MESH:D053138] <169> | (58|70) |
(62|34|16) |
| - 1: | Carotenoids [MESH:D002338] <145> | (58|69) |
(62|33|16) |
| - 1: | Shikimic Acid [MESH:D012765] <33> | (0|0) |
(0|0|0) |
| - 1: | Oseltamivir [MESH:D053139] <5> | (0|0) |
(0|0|0) |
| - 1: | Chorismic Acid [MESH:D002827] <4> | (0|0) |
(0|0|0) |
| - 1: | Limonene [MESH:D000077222] <1> | (1|1) |
(1|0|0) |
| - 1: | (1R,2R,3R,6S)-pipoxide [MESH:C000613132] | (0|0) |
(0|0|0) |
| - 1: | (2E,6E)-2-methyl-6-(4-methylcyclohex-3-enylidene)hept-2-enal [MESH:C585680] | (0|0) |
(0|0|0) |
| - 1: | (2R,3Z,5Z)-2,7-diacetoxyhepta-3,5-dienylbenzoate [MESH:C000610930] | (0|0) |
(0|0|0) |
| - 1: | (2S)-5,2',6'-trihydroxy-8-prenyl-6,7-(3-prenyl-2,2-dimethyl-1-keone-cyclohexadiene)-flavanone [MESH:C531095] | (0|0) |
(0|0|0) |
| - 1: | (2S)-5,2',6'-trihydroxy-8-prenyl-6,7-(3-prenyl-2,2-dimethylpyrano)-3',4'-(2,2-dimethyl-1-keone-cyclo [MESH:C531094] | (0|0) |
(0|0|0) |
| - 1: | (3R,4R,5S)-4-acetylamino-5-amino-3-hydroxy- cyclohex-1-ene-carboxylic acid ethyl ester [MESH:C520591] | (0|0) |
(0|0|0) |
| - 1: | (3R,4R,5S,)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid [MESH:C508640] | (0|0) |
(0|0|0) |
| - 1: | (5R)-5-isopropenyl-2-methyl-2-cyclohexene-1-hydroperoxide [MESH:C547966] | (0|0) |
(0|0|0) |
| - 1: | (E)-2-(5-phenylpent-2-en-4-ynamido)cyclohex-1-ene-1-carboxylate [MESH:C000621757] | (0|0) |
(0|0|0) |
| - 1: | (E)-2-tert-butyl-6-((2-(7-chloroquinolin-4-ylamino)ethylamino)methylene)-4-((E)-3-(4-fluorophenyl)-3 [MESH:C574184] | (0|0) |
(0|0|0) |
| - 1: | (E)-4-((E)-3-(4-bromophenyl)-3-oxoprop-1-enyl)-2-tert-butyl-6-((2-(7-chloroquinolin-4-ylamino)ethyla [MESH:C574183] | (0|0) |
(0|0|0) |
| - 1: | (Z)-4-((E)-p-tolyldiazenyl)-6-((2-hydroxyphenylamino)methylene)-2-methoxycyclohexa-2,4-dienone [MESH:C573999] | (0|0) |
(0|0|0) |
| - 1: | 1,1'-bis-valienamine [MESH:C551747] | (0|0) |
(0|0|0) |
| - 1: | 1,2,3,3,4,4,5,5,6,6-decafluorocyclohex-1-ene [MESH:C000588980] | (0|0) |
(0|0|0) |
| - 1: | 1,2,5,6-tetrahydrocuminic acid [MESH:C000623038] | (0|0) |
(0|0|0) |
| - 1: | 1,2-diaminocyclohexane-bis(shikimato)platinum(II) [MESH:C070612] | (0|0) |
(0|0|0) |
| - 1: | 1,3,5,5-trimethyl-2-cyclohexen-1-ylidine-2-propanone [MESH:C579616] | (0|0) |
(0|0|0) |
| - 1: | 1,3-cyclohexadiene [MESH:C034005] | (0|0) |
(0|0|0) |
| - 1: | 1,4-cyclohexadiene [MESH:C048401] | (0|0) |
(0|0|0) |
| - 1: | 1-(1',4'-cyclohexadienyl)-2-methylaminopropane [MESH:C572389] | (0|0) |
(0|0|0) |
| - 1: | 1-(1-hydroperoxy-1-methylethyl) cyclohexene [MESH:C547967] | (0|0) |
(0|0|0) |
| - 1: | 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)pent-1-en-3-one [MESH:C000589237] | (0|0) |
(0|0|0) |
| - 1: | 1-(2,6,6-trimethylcyclohex-1-enyl)ethanol [MESH:C541164] | (0|0) |
(0|0|0) |
| - 1: | 1-(2-aminoethyl)-1,4-cyclohexadiene [MESH:C401839] | (0|0) |
(0|0|0) |
| - 1: | 1-(3,5,6-trimethyl-3-cyclohexen-1-yl)ethan-1-one [MESH:C000589216] | (0|0) |
(0|0|0) |
| - 1: | 1-(4,4-dimethyl-2, 6-dioxocyclohex-1-ylidene)ethyl [MESH:C000606031] | (0|0) |
(0|0|0) |
| - 1: | 1-(4-phenyl-cyclohex-1-enyl)-pyrrolidine [MESH:C577217] | (0|0) |
(0|0|0) |
| - 1: | 1-(5,5-dimethylcyclohexen-1-yl)pent-4-en-1-one [MESH:C000589157] | (0|0) |
(0|0|0) |
| - 1: | 1-cyclohexene-1-carboxylic acid-5-hydroxy-3,4-isopropylidine-dioxy [MESH:C061985] | (0|0) |
(0|0|0) |
| - 1: | 1-pyrrolidino-1-cyclohexene [MESH:C585851] | (0|0) |
(0|0|0) |
| - 1: | 15-hydroxytrichodiene [MESH:C103559] | (0|0) |
(0|0|0) |
| - 1: | 2,3,5,6-tetraethyleneimino-1,4-benzoquinone [MESH:C020942] | (0|0) |
(0|0|0) |
| - 1: | 2,3,5-trimethoxy-6-(1-propenyl)-2,5-cyclohexadiene-1,4-dione [MESH:C472845] | (0|0) |
(0|0|0) |
| - 1: | 2,3-dimethyl-2,5-cyclohexadiene-1,4 dione [MESH:C036353] | (0|0) |
(0|0|0) |
| - 1: | 2,5-bis(1-aziridinyl)-3,6-bis(2-methoxyethoxy)-4-benzoquinone [MESH:C006052] | (0|0) |
(0|0|0) |
| - 1: | 2,5-cyclohexadiene-1-carboxylic acid [MESH:C568938] | (0|0) |
(0|0|0) |
| - 1: | 2,5-diaziridinyl-3-hydroxymethyl-6-methyl-cyclohexa-2,5-diene-1,4-dione [MESH:C000612301] | (0|0) |
(0|0|0) |
| - 1: | 2,5-dichloro-2,5-cyclohexadiene-1,4-diol [MESH:C087473] | (0|0) |
(0|0|0) |
| - 1: | 2,5-dihydrophenylalanine [MESH:C004174] | (0|0) |
(0|0|0) |
| - 1: | 2,5-dihydroxy-3,6-dinitro-2,5-cyclohexadiene-1,4-dione [MESH:C000591936] | (0|0) |
(0|0|0) |
| - 1: | 2,5-dimethyl-4-benzoquinone [MESH:C020617] | (0|0) |
(0|0|0) |
| - 1: | 2-(4''-hydroxybenzyl)-3-(3'-hydroxyphenethyl)-5-methoxy-cyclohexa-2,5-diene-1,4-dione [MESH:C539682] | (0|0) |
(0|0|0) |
| - 1: | 2-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione [MESH:C581182] | (0|0) |
(0|0|0) |
| - 1: | 3,4-cyclohexene-8-(3-dimethylaminopropoxy)-4'-methylfuro(3,2-g)coumarin [MESH:C477190] | (0|0) |
(0|0|0) |
| - 1: | 3,4-cyclohexene-8-hydroxy-4'-methylfuro(3,2-g)coumarin [MESH:C477189] | (0|0) |
(0|0|0) |
| - 1: | 3,4-dihydroxy-6-oxo-1-cyclohexene-1-acetonitrile [MESH:C465100] | (0|0) |
(0|0|0) |
| - 1: | 3-(methylamino)avarone [MESH:C000630643] | (0|0) |
(0|0|0) |
| - 1: | 3-O-debenzoylzeylenone [MESH:C573511] | (0|0) |
(0|0|0) |
| - 1: | 3-bromo-3,5-cyclohexadiene-1,2-diol [MESH:C041284] | (0|0) |
(0|0|0) |
| - 1: | 3-cyclohexene-1-carboxylic acid [MESH:C004706] | (0|0) |
(0|0|0) |
| - 1: | 3-fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid [MESH:C488433] | (0|0) |
(0|0|0) |
| - 1: | 3-methyl-4,5-cyclohexadiene-1,2-diol [MESH:C118832] | (0|0) |
(0|0|0) |
| - 1: | 3-methyl-4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one [MESH:C526430] | (0|0) |
(0|0|0) |
| - 1: | 3R-(3,4-dimethoxyphenyl)-4S-((E)-3,4-dimethoxystyryl)cyclohex-1-ene [MESH:C587213] | (0|0) |
(0|0|0) |
| - 1: | 4'-(methylamino)avarone [MESH:C000630675] | (0|0) |
(0|0|0) |
| - 1: | 4'-leucine-avarone [MESH:C000591438] | (0|0) |
(0|0|0) |
| - 1: | 4,4-dimethyl-2-vinylcyclohexene [MESH:C580610] | (0|0) |
(0|0|0) |
| - 1: | 4,5-dimethylenecyclohex-1-ene [MESH:C586179] | (0|0) |
(0|0|0) |
| - 1: | 4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one [MESH:C526431] | (0|0) |
(0|0|0) |
| - 1: | 4-(3-cyclohexen-1-yl)pyridine [MESH:C529667] | (0|0) |
(0|0|0) |
| - 1: | 4-FTSC [MESH:C000627604] | (0|0) |
(0|0|0) |
| - 1: | 4-cyclohexene-1,2-dicarboxylic acid dinonyl ester [MESH:C000632784] | (0|0) |
(0|0|0) |
| - 1: | 4-nitro-5-(2,3,4-trimethoxyphenyl)cyclohexene [MESH:C433933] | (0|0) |
(0|0|0) |
| - 1: | 4-vinyl-1-cyclohexene dioxide [MESH:C012606] | (0|0) |
(0|0|0) |
| - 1: | 4-vinylcyclohexene [MESH:C013733] | (0|0) |
(0|0|0) |
| - 1: | 4-vinylcyclohexene 1,2 monoepoxide [MESH:C000624423] | (0|0) |
(0|0|0) |
| - 1: | 4-vinylcyclohexene monooxide [MESH:C030595] | (0|0) |
(0|0|0) |
| - 1: | 5,6-diacetoxy1-benzoyloxymethyl-1,3-cyclohexadiene [MESH:C000628693] | (0|0) |
(0|0|0) |
| - 1: | 5-isopropenyl-2-methyl-1-(N-(2-phenylcyclohexyloxycarbonyl)amino)-2-cyclohexene [MESH:C071571] | (0|0) |
(0|0|0) |
| - 1: | 5-nitro-4,6-diphenylcyclohex-1-enecarboxylic ester [MESH:C546295] | (0|0) |
(0|0|0) |
| - 1: | 6-amino-1-formyl-5-hydroxy-1,3-cyclohexadiene [MESH:C012129] | (0|0) |
(0|0|0) |
| - 1: | 6-bromoconduritol [MESH:C036388] | (0|0) |
(0|0|0) |
| - 1: | 6-hydroxy-4-(1-hydroxy-1-methylethyl)-1-cyclohexene-1-ethanol [MESH:C065237] | (0|0) |
(0|0|0) |
| - 1: | 6-hydroxy-6-methylcyclohex-2-en-1-one [MESH:C573161] | (0|0) |
(0|0|0) |
| - 1: | 6-methoxycarbonyl-3-cyclohexene-1-carboxylic acid [MESH:C064173] | (0|0) |
(0|0|0) |
| - 1: | 9-(2'-propylcyclohex-4'-en-1'-yl)nonanoic acid [MESH:C029619] | (0|0) |
(0|0|0) |
| - 1: | A 31472 [MESH:C068882] | (0|0) |
(0|0|0) |
| - 1: | EM 405 [MESH:C069436] | (0|0) |
(0|0|0) |
| - 1: | O-demethylpaulomycin A [MESH:C057871] | (0|0) |
(0|0|0) |
| - 1: | O-demethylpaulomycin B [MESH:C057873] | (0|0) |
(0|0|0) |
| - 1: | P-menth-3-en-7-ol [MESH:C000623040] | (0|0) |
(0|0|0) |
| - 1: | SS220 [MESH:C500473] | (0|0) |
(0|0|0) |
| - 1: | acetylcyclohexene [MESH:C520380] | (0|0) |
(0|0|0) |
| - 1: | acutudaurin [MESH:C424625] | (0|0) |
(0|0|0) |
| - 1: | aeroplysinin [MESH:C001569] | (0|0) |
(0|0|0) |
| - 1: | aeroplysinin I [MESH:C042151] | (0|0) |
(0|0|0) |
| - 1: | aglycone 4-hydroxy-2,6,6-trimethyl-1-carboxyaldehyde-1-cyclohexene [MESH:C413286] | (0|0) |
(0|0|0) |
| - 1: | allyl alpha-ionone [MESH:C526345] | (0|0) |
(0|0|0) |
| - 1: | alpha-(4-isobutyl(cyclohexen-1-yl))propionic acid [MESH:C011596] | (0|0) |
(0|0|0) |
| - 1: | asperpentyn [MESH:C538695] | (0|0) |
(0|0|0) |
| - 1: | avarone [MESH:C046374] | (0|0) |
(0|0|0) |
| - 1: | azarole [MESH:C039779] | (0|0) |
(0|0|0) |
| - 1: | bonianol A [MESH:C579382] | (0|0) |
(0|0|0) |
| - 1: | bonianol B [MESH:C579381] | (0|0) |
(0|0|0) |
| - 1: | captafol [MESH:C001614] | (1|0) |
(1|0|0) |
| - 1: | chloridazondihydrodiol [MESH:C018867] | (0|0) |
(0|0|0) |
| - 1: | cis-1,2-dihydroxy-cyclohexa-3,5-diene-1-carboxylate [MESH:C533970] | (0|0) |
(0|0|0) |
| - 1: | cis-alpha-damascone [MESH:C526346] | (0|0) |
(0|0|0) |
| - 1: | cleistenechlorohydrin A [MESH:C000621500] | (0|0) |
(0|0|0) |
| - 1: | cleistenechlorohydrin B [MESH:C000621501] | (0|0) |
(0|0|0) |
| - 1: | cleistophenolide [MESH:C000621499] | (0|0) |
(0|0|0) |
| - 1: | conduritol B [MESH:C090988] | (0|0) |
(0|0|0) |
| - 1: | cyclohexadiene-1,2-diol-1-carboxylic acid [MESH:C000533] | (0|0) |
(0|0|0) |
| - 1: | cyclohexadienone [MESH:C507608] | (0|0) |
(0|0|0) |
| - 1: | cyclohexene [MESH:C052568] | (0|0) |
(0|0|0) |
| - 1: | cyclohexene oxide [MESH:C007193] | (0|0) |
(0|0|0) |
| - 1: | cyclohexenyl-G [MESH:C442681] | (0|0) |
(0|0|0) |
| - 1: | fenestrel [MESH:C004381] | (0|0) |
(0|0|0) |
| - 1: | filicinic acid [MESH:C000627729] | (0|0) |
(0|0|0) |
| - 1: | flexuvarin [MESH:C000610931] | (0|0) |
(0|0|0) |
| - 1: | formyl cyclohexadiene [MESH:C415402] | (0|0) |
(0|0|0) |
| - 1: | gacyclidine [MESH:C070707] | (0|0) |
(0|0|0) |
| - 1: | harveynone [MESH:C538696] | (0|0) |
(0|0|0) |
| - 1: | hawkinsin [MESH:C014578] | (0|0) |
(0|0|0) |
| - 1: | humulon [MESH:C007966] | (0|0) |
(0|0|0) |
| - 1: | hyaladione [MESH:C573609] | (0|0) |
(0|0|0) |
| - 1: | hydroxyisohexyl 3-cyclohexene carboxaldehyde [MESH:C092244] | (0|0) |
(0|0|0) |
| - 1: | hydroxyperezone [MESH:C061612] | (0|0) |
(0|0|0) |
| - 1: | indaniline [MESH:C041294] | (0|0) |
(0|0|0) |
| - 1: | isogabaculine [MESH:C019441] | (0|0) |
(0|0|0) |
| - 1: | kweichowenol C [MESH:C539210] | (0|0) |
(0|0|0) |
| - 1: | kweichowenol D [MESH:C539211] | (0|0) |
(0|0|0) |
| - 1: | methanotetramethrin [MESH:C039473] | (0|0) |
(0|0|0) |
| - 1: | methyl 1-hydroxy-6-oxo-2-cyclohexenecarboxylate [MESH:C524933] | (0|0) |
(0|0|0) |
| - 1: | methyl trisporate E [MESH:C041423] | (0|0) |
(0|0|0) |
| - 1: | oryzoxymycin [MESH:C002624] | (0|0) |
(0|0|0) |
| - 1: | oxime V [MESH:C047389] | (0|0) |
(0|0|0) |
| - 1: | p-menth-3-en-7-al [MESH:C000623039] | (0|0) |
(0|0|0) |
| - 1: | paulomenol A [MESH:C057874] | (0|0) |
(0|0|0) |
| - 1: | paulomenol B [MESH:C057875] | (0|0) |
(0|0|0) |
| - 1: | paulomycin A2 [MESH:C055552] | (0|0) |
(0|0|0) |
| - 1: | paulomycin C [MESH:C055553] | (0|0) |
(0|0|0) |
| - 1: | paulomycin D [MESH:C055554] | (0|0) |
(0|0|0) |
| - 1: | paulomycin E [MESH:C055555] | (0|0) |
(0|0|0) |
| - 1: | paulomycin F [MESH:C055556] | (0|0) |
(0|0|0) |
| - 1: | paulomycin G [MESH:C000626953] | (0|0) |
(0|0|0) |
| - 1: | perillartine [MESH:C024527] | (0|0) |
(0|0|0) |
| - 1: | perillic acid [MESH:C078706] | (0|0) |
(0|0|0) |
| - 1: | picrionoside A [MESH:C000609212] | (0|0) |
(0|0|0) |
| - 1: | picrocrocin [MESH:C087962] | (0|0) |
(0|0|0) |
| - 1: | platyphyllide [MESH:C551783] | (0|0) |
(0|0|0) |
| - 1: | poly(cyclohexene carbonate) [MESH:C556577] | (0|0) |
(0|0|0) |
| - 1: | prephenic acid [MESH:C005550] | (0|0) |
(0|0|0) |
| - 1: | prephenyllactate [MESH:C057673] | (0|0) |
(0|0|0) |
| - 1: | pretyrosine [MESH:C015478] | (0|0) |
(0|0|0) |
| - 1: | rel-labd-12-en-15(16)-olid-7-one-8R-spiro-1'-(2S-(2,4,5-trimethoxyphenyl)-3-cyclohexene) [MESH:C430171] | (0|0) |
(0|0|0) |
| - 1: | safranal [MESH:C087963] | (0|0) |
(0|0|0) |
| - 1: | salbostatin [MESH:C532922] | (0|0) |
(0|0|0) |
| - 1: | semipinacol [MESH:C519041] | (0|0) |
(0|0|0) |
| - 1: | siglure [MESH:C045212] | (0|0) |
(0|0|0) |
| - 1: | tac-302 [MESH:C000654176] | (0|0) |
(0|0|0) |
| - 1: | tetrahydrophthalamic acid [MESH:C014844] | (0|0) |
(0|0|0) |
| - 1: | trans,cis-4-hydroxy-5,6-di-O-isopropylidenecyclohex-2-ene-1-one [MESH:C558604] | (0|0) |
(0|0|0) |
| - 1: | trans-3-(3,4-dimethoxyphenyl)-4-((E)-3,4-dimethoxystyryl)cyclohex-1-ene [MESH:C522789] | (0|0) |
(0|0|0) |
| - 1: | trichodiene [MESH:C012075] | (0|0) |
(0|0|0) |
| - 1: | tricholomenyn A [MESH:C538697] | (0|0) |
(0|0|0) |
| - 1: | uvacanol F [MESH:C551930] | (0|0) |
(0|0|0) |
| - 1: | uvacanol G [MESH:C551931] | (0|0) |
(0|0|0) |
| - 1: | uvacanol H [MESH:C551932] | (0|0) |
(0|0|0) |
| - 1: | uvaridacane A [MESH:C574814] | (0|0) |
(0|0|0) |
| - 1: | uvaridacane B [MESH:C574815] | (0|0) |
(0|0|0) |
| - 1: | valienamine [MESH:C030791] | (0|0) |
(0|0|0) |
| - 1: | valienone [MESH:C586497] | (0|0) |
(0|0|0) |
| - 1: | zeylenol [MESH:C573512] | (0|0) |
(0|0|0) |
Jump to [ Top · Hierarchy ]
Superfamily( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| BAG domain | 0 | DIRECT |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| Di-copper centre-containing domain | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Alanine racemase C-terminal domain-like | 0 | DIRECT |
| PLP-binding barrel | 0 | DIRECT |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | DIRECT |
| A heparin-binding domain | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Nuclear receptor ligand-binding domain | 0.000000000203 | DIRECT |
| Leucine zipper domain | 0.00006266 | DIRECT |
| Thyroglobulin type-1 domain | 0.00009562 | DIRECT |
| Integrin domains | 0.000133 | DIRECT |
| SMAD MH1 domain | 0.000486 | DIRECT |
| A DNA-binding domain in eukaryotic transcription factors | 0.00165 | INHERITED FROM: Tretinoin || Vitamin A |
| Aminoacid dehydrogenase-like, N-terminal domain | 0.002662 | INHERITED FROM: Tretinoin || Vitamin A |
| Single hybrid motif | 0.003403 | INHERITED FROM: Isotretinoin |
| ALDH-like | 0.003475 | INHERITED FROM: Retinaldehyde || apocarotenal |
| GroES-like | 0.01152 | INHERITED FROM: apocarotenal |
| ClpP/crotonase | 0.02878 | INHERITED FROM: Isotretinoin |
| Interleukin 8-like chemokines | 0.03584 | INHERITED FROM: beta Carotene |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.03698 | INHERITED FROM: Retinaldehyde || SR 11237 || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Alitretinoin || beta Carotene || 9-cis-retinal || Bexarotene || Fenretinide || 4-hydroxyretinoic acid || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid |
| BTG domain-like | 0.04274 | INHERITED FROM: LG 100815 |
| NAD(P)-linked oxidoreductase | 0.04629 | INHERITED FROM: Retinaldehyde || 9-cis-retinal |
| Homeodomain-like | 0.05099 | INHERITED FROM: apocarotenal || beta Carotene |
| TK C-terminal domain-like | 0.09707 | INHERITED FROM: Isotretinoin |
| Cytochrome P450 | 0.1051 | INHERITED FROM: 4-oxoretinoic acid || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Alitretinoin || Limonene || 4-hydroxyretinoic acid |
| Sm-like ribonucleoproteins | 0.1108 | INHERITED FROM: CD 437 |
| Thiolase-like | 0.1327 | INHERITED FROM: Isotretinoin |
| Zn-binding ribosomal proteins | 0.1327 | INHERITED FROM: CD 437 |
| Ribosomal protein S5 domain 2-like | 0.1461 | INHERITED FROM: CD 437 |
| Intermediate filament protein, coiled coil region | 0.1769 | INHERITED FROM: 4-oxoretinoic acid || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || beta Carotene || Isotretinoin || 4-oxoretinol |
| Nucleic acid-binding proteins | 0.1886 | INHERITED FROM: CD 437 |
| Mitochondrial carrier | 0.1941 | INHERITED FROM: CD 437 |
| Cytochrome b5-like heme/steroid binding domain | 0.2163 | INHERITED FROM: Isotretinoin |
| 4-helical cytokines | 0.2422 | INHERITED FROM: Alitretinoin || apocarotenal |
| Carbon-nitrogen hydrolase | 0.2729 | INHERITED FROM: Isotretinoin |
| LuxS/MPP-like metallohydrolase | 0.2729 | INHERITED FROM: Isotretinoin |
| NAD(P)-binding Rossmann-fold domains | 0.3163 | INHERITED FROM: Isotretinoin || Retinoids |
| Cyclin-like | 0.349 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
| Frizzled cysteine-rich domain | 0.4971 | INHERITED FROM: Tretinoin || Vitamin A |
| Prefoldin | 0.5574 | INHERITED FROM: 4-oxoretinoic acid || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || beta Carotene || Bexarotene || 4-oxoretinol |
| BRCT domain | 0.6261 | INHERITED FROM: Fenretinide |
| GST C-terminal domain-like | 0.6467 | INHERITED FROM: apocarotenal || beta Carotene |
| Protein kinase-like (PK-like) | 0.7395 | INHERITED FROM: Lycopene || beta-ionone |
| CoA-dependent acyltransferases | 0.7428 | INHERITED FROM: Isotretinoin |
| Lipocalins | 0.7711 | INHERITED FROM: 4-oxoretinoic acid |
| GroEL apical domain-like | 0.7844 | INHERITED FROM: CD 437 |
| GroEL-intermediate domain like | 0.7844 | INHERITED FROM: CD 437 |
| GroEL equatorial domain-like | 0.8285 | INHERITED FROM: CD 437 |
| FAD/NAD(P)-binding domain | 0.8641 | INHERITED FROM: Xanthophylls |
| Thioredoxin-like | 1 | INHERITED FROM: apocarotenal || beta Carotene || captafol |
| Bcl-2 inhibitors of programmed cell death | 1 | INHERITED FROM: Xanthophylls || Lutein || beta Carotene || Fenretinide |
| Caspase-like | 1 | INHERITED FROM: CD 437 || Acitretin || Xanthophylls || Fenretinide |
| DEATH domain | 1 | INHERITED FROM: Acitretin || beta Carotene || Fenretinide |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Family( show details)
Highlighted in gray are those with FDR_all>0.001
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| IP3 receptor type 1 binding core, domain 2 | 0 | DIRECT |
| Phosphoglucomutase, C-terminal domain | 0 | DIRECT |
| DEATH effector domain, DED | 0 | DIRECT |
| PAS domain of steroid receptor coactivator 1A, NCo-A1 | 0 | DIRECT |
| Oligoxyloglucan reducing end-specific cellobiohydrolase | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| p53 DNA-binding domain-like | 0 | DIRECT |
| CAT-like | 0 | DIRECT |
| Eukaryotic ODC-like | 0 | DIRECT |
| Cystathionine synthase-like | 0 | DIRECT |
| Biotin dependent carboxylase carboxyltransferase domain | 0 | DIRECT |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Alanine racemase-like, N-terminal domain | 0 | DIRECT |
| Isoprenyl diphosphate synthases | 0 | DIRECT |
| 1,3-glucuronyltransferase | 0 | DIRECT |
| Calnexin/calreticulin | 0 | DIRECT |
| Malic enzyme N-domain | 0 | DIRECT |
| A heparin-binding domain | 0 | DIRECT |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | DIRECT |
| BAG domain | 0 | DIRECT |
| Nuclear receptor ligand-binding domain | 0.0000000006719 | DIRECT |
| Nuclear receptor | 0.000000004068 | DIRECT |
| Growth factor receptor domain | 0.0001133 | DIRECT |
| Thyroglobulin type-1 domain | 0.0001317 | DIRECT |
| Leucine zipper domain | 0.0001356 | DIRECT |
| C2 set domains | 0.0001834 | DIRECT |
| Integrin domains | 0.000206 | DIRECT |
| SMAD MH1 domain | 0.0005475 | DIRECT |
| SMAD domain | 0.0005475 | DIRECT |
| Short-chain cytokines | 0.0006445 | DIRECT |
| Integrin alpha N-terminal domain | 0.0009841 | DIRECT |
| MIF4G domain-like | 0.001149 | INHERITED FROM: Tretinoin || Vitamin A |
| A DNA-binding domain in eukaryotic transcription factors | 0.002128 | INHERITED FROM: Tretinoin || Vitamin A |
| Biotinyl/lipoyl-carrier proteins and domains | 0.003996 | INHERITED FROM: Isotretinoin |
| ALDH-like | 0.004557 | INHERITED FROM: Retinaldehyde || apocarotenal |
| Alcohol dehydrogenase-like, C-terminal domain | 0.004723 | INHERITED FROM: apocarotenal |
| Alcohol dehydrogenase-like, N-terminal domain | 0.01651 | INHERITED FROM: apocarotenal |
| BTG domain-like | 0.04478 | INHERITED FROM: LG 100815 |
| Interleukin 8-like chemokines | 0.05064 | INHERITED FROM: beta Carotene |
| Homeodomain | 0.0542 | INHERITED FROM: apocarotenal || beta Carotene |
| Aldo-keto reductases (NADP) | 0.05424 | INHERITED FROM: Retinaldehyde || 9-cis-retinal |
| Branched-chain alpha-keto acid dehydrogenase beta-subunit, C-terminal-domain | 0.09867 | INHERITED FROM: Isotretinoin |
| Cytochrome P450 | 0.1028 | INHERITED FROM: 4-oxoretinoic acid || Limonene || 4-hydroxyretinoic acid |
| S100 proteins | 0.129 | INHERITED FROM: 4-oxoretinoic acid || Alitretinoin |
| Cytochrome b5 | 0.1407 | INHERITED FROM: Isotretinoin |
| Intermediate filament protein, coiled coil region | 0.1631 | INHERITED FROM: 4-oxoretinoic acid || ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || beta Carotene || Isotretinoin || 4-oxoretinol |
| EGF-type module | 0.1708 | INHERITED FROM: Retinoids |
| Thiolase-related | 0.1831 | INHERITED FROM: Isotretinoin |
| Mitochondrial carrier | 0.2134 | INHERITED FROM: CD 437 |
| Laminin G-like module | 0.2557 | INHERITED FROM: Retinoids |
| MPP-like | 0.2779 | INHERITED FROM: Isotretinoin |
| Sm motif of small nuclear ribonucleoproteins, SNRNP | 0.3174 | INHERITED FROM: CD 437 |
| Interferons/interleukin-10 (IL-10) | 0.3336 | INHERITED FROM: apocarotenal || beta Carotene |
| Cyclin | 0.4179 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
| Tyrosine-dependent oxidoreductases | 0.4465 | INHERITED FROM: Isotretinoin |
| Translational machinery components | 0.4697 | INHERITED FROM: CD 437 |
| Frizzled cysteine-rich domain | 0.472 | INHERITED FROM: Tretinoin || Vitamin A |
| Prefoldin | 0.4861 | INHERITED FROM: 4-oxoretinoic acid || Alitretinoin |
| Protein kinases, catalytic subunit | 0.6243 | INHERITED FROM: Lycopene || beta-ionone |
| Glutathione S-transferase (GST), C-terminal domain | 0.7227 | INHERITED FROM: apocarotenal || beta Carotene |
| Glutathione S-transferase (GST), N-terminal domain | 0.7748 | INHERITED FROM: apocarotenal || beta Carotene |
| Group II chaperonin (CCT, TRIC), apical domain | 0.8065 | INHERITED FROM: CD 437 |
| Group II chaperonin (CCT, TRIC), ATPase domain | 0.8541 | INHERITED FROM: CD 437 |
| Caspase catalytic domain | 1 | INHERITED FROM: CD 437 || Acitretin || Xanthophylls || Fenretinide |
| DEATH domain, DD | 1 | INHERITED FROM: apocarotenal || beta Carotene |
| Bcl-2 inhibitors of programmed cell death | 1 | INHERITED FROM: Xanthophylls || Lutein || beta Carotene || Fenretinide |
| SCOP term |
FDR (all) |
Annotation (direct or inherited) |
| Nuclear receptor coactivator interlocking domain | 0 | Direct |
| p53 tetramerization domain | 0 | Direct |
| IP3 receptor type 1 binding core, domain 2 | 0 | Direct |
| Phosphoglucomutase, C-terminal domain | 0 | Direct |
| DEATH effector domain, DED | 0 | Direct |
| PAS domain of steroid receptor coactivator 1A, NCo-A1 | 0 | Direct |
| Oligoxyloglucan reducing end-specific cellobiohydrolase | 0 | Direct |
| P-domain of calnexin/calreticulin | 0 | Direct |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | Direct |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| p53 DNA-binding domain-like | 0 | Direct |
| CAT-like | 0 | Direct |
| Eukaryotic ODC-like | 0 | Direct |
| Cystathionine synthase-like | 0 | Direct |
| Biotin dependent carboxylase carboxyltransferase domain | 0 | Direct |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
| Alanine racemase-like, N-terminal domain | 0 | Direct |
| Isoprenyl diphosphate synthases | 0 | Direct |
| 1,3-glucuronyltransferase | 0 | Direct |
| Calnexin/calreticulin | 0 | Direct |
| Malic enzyme N-domain | 0 | Direct |
| A heparin-binding domain | 0 | Direct |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | Direct |
| BAG domain | 0 | Direct |
| Nuclear receptor ligand-binding domain | 0.0000000006719 | Direct |
| Nuclear receptor | 0.000000004068 | Direct |
| Growth factor receptor domain | 0.0001133 | Direct |
| Thyroglobulin type-1 domain | 0.0001317 | Direct |
| Leucine zipper domain | 0.0001356 | Direct |
| C2 set domains | 0.0001834 | Direct |
| Integrin domains | 0.000206 | Direct |
| SMAD MH1 domain | 0.0005475 | Direct |
| SMAD domain | 0.0005475 | Direct |
| Short-chain cytokines | 0.0006445 | Direct |
| Integrin alpha N-terminal domain | 0.0009841 | Direct |
| MIF4G domain-like | 0.001149 | Inherited |
| A DNA-binding domain in eukaryotic transcription factors | 0.002128 | Inherited |
| Biotinyl/lipoyl-carrier proteins and domains | 0.003996 | Inherited |
| ALDH-like | 0.004557 | Inherited |
| Alcohol dehydrogenase-like, C-terminal domain | 0.004723 | Inherited |
| Alcohol dehydrogenase-like, N-terminal domain | 0.01651 | Inherited |
| BTG domain-like | 0.04478 | Inherited |
| Interleukin 8-like chemokines | 0.05064 | Inherited |
| Homeodomain | 0.0542 | Inherited |
| Aldo-keto reductases (NADP) | 0.05424 | Inherited |
| Branched-chain alpha-keto acid dehydrogenase beta-subunit, C-terminal-domain | 0.09867 | Inherited |
| Cytochrome P450 | 0.1028 | Inherited |
| S100 proteins | 0.129 | Inherited |
| Cytochrome b5 | 0.1407 | Inherited |
| Intermediate filament protein, coiled coil region | 0.1631 | Inherited |
| EGF-type module | 0.1708 | Inherited |
| Thiolase-related | 0.1831 | Inherited |
| Mitochondrial carrier | 0.2134 | Inherited |
| Laminin G-like module | 0.2557 | Inherited |
| MPP-like | 0.2779 | Inherited |
| Sm motif of small nuclear ribonucleoproteins, SNRNP | 0.3174 | Inherited |
| Interferons/interleukin-10 (IL-10) | 0.3336 | Inherited |
| Cyclin | 0.4179 | Inherited |
| Tyrosine-dependent oxidoreductases | 0.4465 | Inherited |
| Translational machinery components | 0.4697 | Inherited |
| Frizzled cysteine-rich domain | 0.472 | Inherited |
| Prefoldin | 0.4861 | Inherited |
| Protein kinases, catalytic subunit | 0.6243 | Inherited |
| Glutathione S-transferase (GST), C-terminal domain | 0.7227 | Inherited |
| Glutathione S-transferase (GST), N-terminal domain | 0.7748 | Inherited |
| Group II chaperonin (CCT, TRIC), apical domain | 0.8065 | Inherited |
| Group II chaperonin (CCT, TRIC), ATPase domain | 0.8541 | Inherited |
| Caspase catalytic domain | 1 | Inherited |
| DEATH domain, DD | 1 | Inherited |
| Bcl-2 inhibitors of programmed cell death | 1 | Inherited |
LINKTO: Domain2BO Download and Domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Single)( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Single) |
FDR (all) |
Annotation (direct or inherited) |
| A heparin-binding domain | 0 | DIRECT |
| Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
| p53 tetramerization domain | 0 | DIRECT |
| CAPPD, an extracellular domain of amyloid beta A4 protein | 0 | DIRECT |
| BAG domain | 0 | DIRECT |
| Di-copper centre-containing domain | 0 | DIRECT |
| C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| Alanine racemase C-terminal domain-like | 0 | DIRECT |
| PLP-binding barrel | 0 | DIRECT |
| Nuclear receptor coactivator interlocking domain | 0 | DIRECT |
| N-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
| P-domain of calnexin/calreticulin | 0 | DIRECT |
| Nuclear receptor ligand-binding domain | 0.00000000008189 | DIRECT |
| Leucine zipper domain | 0.00003292 | DIRECT |
| Thyroglobulin type-1 domain | 0.00005117 | DIRECT |
| Integrin domains | 0.00007214 | DIRECT |
| SMAD MH1 domain | 0.0002797 | DIRECT |
| A DNA-binding domain in eukaryotic transcription factors | 0.001011 | INHERITED FROM: Retinoids || Tretinoin || Vitamin A |
| Aminoacid dehydrogenase-like, N-terminal domain | 0.00167 | INHERITED FROM: Tretinoin || Vitamin A |
| Single hybrid motif | 0.00216 | INHERITED FROM: Isotretinoin |
| ALDH-like | 0.002209 | INHERITED FROM: Retinaldehyde || apocarotenal |
| GroES-like | 0.007825 | INHERITED FROM: apocarotenal |
| ClpP/crotonase | 0.02062 | INHERITED FROM: Isotretinoin |
| Interleukin 8-like chemokines | 0.02603 | INHERITED FROM: beta Carotene |
| Glucocorticoid receptor-like (DNA-binding domain) | 0.0269 | INHERITED FROM: Alitretinoin || 9-cis-retinal || 4-hydroxyretinoic acid || beta Carotene || SR 11237 || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Bexarotene || 4-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-anthracenyl)benzoic acid || Fenretinide || Retinaldehyde |
| BTG domain-like | 0.03135 | INHERITED FROM: LG 100815 |
| NAD(P)-linked oxidoreductase | 0.03413 | INHERITED FROM: 9-cis-retinal || Retinaldehyde |
| Homeodomain-like | 0.0378 | INHERITED FROM: beta Carotene || apocarotenal |
| TK C-terminal domain-like | 0.07448 | INHERITED FROM: Isotretinoin |
| Cytochrome P450 | 0.081 | INHERITED FROM: Alitretinoin || Limonene || 4-hydroxyretinoic acid || 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || 4-oxoretinoic acid |
| Sm-like ribonucleoproteins | 0.08564 | INHERITED FROM: CD 437 |
| Thiolase-like | 0.1036 | INHERITED FROM: Isotretinoin |
| Zn-binding ribosomal proteins | 0.1036 | INHERITED FROM: CD 437 |
| Ribosomal protein S5 domain 2-like | 0.1149 | INHERITED FROM: CD 437 |
| Intermediate filament protein, coiled coil region | 0.1408 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || Isotretinoin || beta Carotene || 4-oxoretinol || 4-oxoretinoic acid |
| Nucleic acid-binding proteins | 0.1508 | INHERITED FROM: CD 437 |
| Mitochondrial carrier | 0.1556 | INHERITED FROM: CD 437 |
| Cytochrome b5-like heme/steroid binding domain | 0.1747 | INHERITED FROM: Isotretinoin |
| 4-helical cytokines | 0.1972 | INHERITED FROM: Alitretinoin || apocarotenal |
| Carbon-nitrogen hydrolase | 0.224 | INHERITED FROM: Isotretinoin |
| LuxS/MPP-like metallohydrolase | 0.224 | INHERITED FROM: Isotretinoin |
| NAD(P)-binding Rossmann-fold domains | 0.2628 | INHERITED FROM: Isotretinoin || Retinoids |
| Thiamin diphosphate-binding fold (THDP-binding) | 0.2725 | INHERITED FROM: Isotretinoin |
| Cyclin-like | 0.2927 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid || Fenretinide |
| Cystine-knot cytokines | 0.3683 | INHERITED FROM: Alitretinoin |
| Frizzled cysteine-rich domain | 0.4301 | INHERITED FROM: Retinoids || Tretinoin || Vitamin A |
| Prefoldin | 0.4871 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || beta Carotene || 4-oxoretinol || Bexarotene || 4-oxoretinoic acid |
| BRCT domain | 0.5546 | INHERITED FROM: Fenretinide |
| GST C-terminal domain-like | 0.5751 | INHERITED FROM: beta Carotene || apocarotenal |
| Protein kinase-like (PK-like) | 0.668 | INHERITED FROM: Lycopene || beta-ionone |
| CoA-dependent acyltransferases | 0.6714 | INHERITED FROM: Isotretinoin |
| Serpins | 0.6753 | INHERITED FROM: Alitretinoin |
| Lipocalins | 0.7006 | INHERITED FROM: 4-oxoretinoic acid |
| GroEL apical domain-like | 0.7145 | INHERITED FROM: CD 437 |
| GroEL-intermediate domain like | 0.7145 | INHERITED FROM: CD 437 |
| MHC antigen-recognition domain | 0.7268 | INHERITED FROM: Isotretinoin |
| GroEL equatorial domain-like | 0.7606 | INHERITED FROM: CD 437 |
| FAD/NAD(P)-binding domain | 0.7986 | INHERITED FROM: Xanthophylls |
| Caspase-like | 0.9679 | INHERITED FROM: Xanthophylls || Acitretin || Fenretinide || CD 437 |
| Thioredoxin-like | 0.9687 | INHERITED FROM: captafol || beta Carotene || apocarotenal |
| Bcl-2 inhibitors of programmed cell death | 1 | INHERITED FROM: Xanthophylls || beta Carotene || Fenretinide || Lutein |
| DEATH domain | 1 | INHERITED FROM: Acitretin || beta Carotene || Fenretinide |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Duplex) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
49562,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain | 0 | DIRECT |
49899,48726
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin | 0 | DIRECT |
51419,50621
51419 - PLP-binding barrel
50621 - Alanine racemase C-terminal domain-like | 0 | DIRECT |
49899,63887
49899 - Concanavalin A-like lectins/glucanases
63887 - P-domain of calnexin/calreticulin | 0 | DIRECT |
52540,47917
52540 - P-loop containing nucleoside triphosphate hydrolases
47917 - C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | DIRECT |
57196,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain | 0 | DIRECT |
49695,50370
49695 - gamma-Crystallin-like
50370 - Ricin B-like lectins | 0 | DIRECT |
53300,49899
53300 - vWA-like
49899 - Concanavalin A-like lectins/glucanases | 0 | DIRECT |
46966,51045
46966 - Spectrin repeat
51045 - WW domain | 0 | DIRECT |
51045,47473
51045 - WW domain
47473 - EF-hand | 0 | DIRECT |
49417,47719
49417 - p53-like transcription factors
47719 - p53 tetramerization domain | 0 | DIRECT |
56491,89811
56491 - A heparin-binding domain
89811 - Amyloid beta a4 protein copper binding domain (domain 2) | 0 | DIRECT |
57716,48508
57716 - Glucocorticoid receptor-like (DNA-binding domain)
48508 - Nuclear receptor ligand-binding domain | 0.000000009054 | DIRECT |
52799,52799
52799 - (Phosphotyrosine protein) phosphatases II
52799 - (Phosphotyrosine protein) phosphatases II | 0.0000002216 | DIRECT |
57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0000003109 | DIRECT |
57184,57184
57184 - Growth factor receptor domain
57184 - Growth factor receptor domain | 0.00006836 | DIRECT |
69318,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.0001599 | DIRECT |
69179,69179
69179 - Integrin domains
69179 - Integrin domains | 0.0001599 | DIRECT |
47454,57959
47454 - A DNA-binding domain in eukaryotic transcription factors
57959 - Leucine zipper domain | 0.0003666 | DIRECT |
46579,64593
46579 - Prefoldin
64593 - Intermediate filament protein, coiled coil region | 0.005564 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || Isotretinoin || beta Carotene || 4-oxoretinol || Bexarotene || 4-oxoretinoic acid |
47954,47954
47954 - Cyclin-like
47954 - Cyclin-like | 0.005793 | INHERITED FROM: 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid |
50129,51735
50129 - GroES-like
51735 - NAD(P)-binding Rossmann-fold domains | 0.009 | INHERITED FROM: apocarotenal |
52518,52922
52518 - Thiamin diphosphate-binding fold (THDP-binding)
52922 - TK C-terminal domain-like | 0.07448 | INHERITED FROM: Isotretinoin |
64593,64593
64593 - Intermediate filament protein, coiled coil region
64593 - Intermediate filament protein, coiled coil region | 0.1594 | INHERITED FROM: ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid || Alitretinoin || beta Carotene || 4-oxoretinoic acid |
53901,53901
53901 - Thiolase-like
53901 - Thiolase-like | 0.1848 | INHERITED FROM: Isotretinoin |
63411,63411
63411 - LuxS/MPP-like metallohydrolase
63411 - LuxS/MPP-like metallohydrolase | 0.224 | INHERITED FROM: Isotretinoin |
52833,47616
52833 - Thioredoxin-like
47616 - GST C-terminal domain-like | 0.6753 | INHERITED FROM: beta Carotene || apocarotenal |
54849,52029
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.7145 | INHERITED FROM: CD 437 |
57440,57440
57440 - Kringle-like
57440 - Kringle-like | 0.7145 | INHERITED FROM: Alitretinoin || Isotretinoin |
54452,48726
54452 - MHC antigen-recognition domain
48726 - Immunoglobulin | 0.7268 | INHERITED FROM: Isotretinoin |
48592,54849
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like | 0.7606 | INHERITED FROM: CD 437 |
47986,52129
47986 - DEATH domain
52129 - Caspase-like | 0.9084 | INHERITED FROM: Fenretinide || CD 437 |
47986,47986
47986 - DEATH domain
47986 - DEATH domain | 0.9528 | INHERITED FROM: Fenretinide |
56112,56112
56112 - Protein kinase-like (PK-like)
56112 - Protein kinase-like (PK-like) | 0.9528 | INHERITED FROM: Lycopene |
| Supra-domain (Duplex) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
49562,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain | 0 | Direct |
49899,48726
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin | 0 | Direct |
51419,50621
51419 - PLP-binding barrel
50621 - Alanine racemase C-terminal domain-like | 0 | Direct |
49899,63887
49899 - Concanavalin A-like lectins/glucanases
63887 - P-domain of calnexin/calreticulin | 0 | Direct |
52540,47917
52540 - P-loop containing nucleoside triphosphate hydrolases
47917 - C-terminal domain of alpha and beta subunits of F1 ATP synthase | 0 | Direct |
57196,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain | 0 | Direct |
49695,50370
49695 - gamma-Crystallin-like
50370 - Ricin B-like lectins | 0 | Direct |
53300,49899
53300 - vWA-like
49899 - Concanavalin A-like lectins/glucanases | 0 | Direct |
46966,51045
46966 - Spectrin repeat
51045 - WW domain | 0 | Direct |
51045,47473
51045 - WW domain
47473 - EF-hand | 0 | Direct |
49417,47719
49417 - p53-like transcription factors
47719 - p53 tetramerization domain | 0 | Direct |
56491,89811
56491 - A heparin-binding domain
89811 - Amyloid beta a4 protein copper binding domain (domain 2) | 0 | Direct |
57716,48508
57716 - Glucocorticoid receptor-like (DNA-binding domain)
48508 - Nuclear receptor ligand-binding domain | 0.000000009054 | Direct |
52799,52799
52799 - (Phosphotyrosine protein) phosphatases II
52799 - (Phosphotyrosine protein) phosphatases II | 0.0000002216 | Direct |
57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0000003109 | Direct |
57184,57184
57184 - Growth factor receptor domain
57184 - Growth factor receptor domain | 0.00006836 | Direct |
69318,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains | 0.0001599 | Direct |
69179,69179
69179 - Integrin domains
69179 - Integrin domains | 0.0001599 | Direct |
47454,57959
47454 - A DNA-binding domain in eukaryotic transcription factors
57959 - Leucine zipper domain | 0.0003666 | Direct |
46579,64593
46579 - Prefoldin
64593 - Intermediate filament protein, coiled coil region | 0.005564 | Inherited |
47954,47954
47954 - Cyclin-like
47954 - Cyclin-like | 0.005793 | Inherited |
50129,51735
50129 - GroES-like
51735 - NAD(P)-binding Rossmann-fold domains | 0.009 | Inherited |
52518,52922
52518 - Thiamin diphosphate-binding fold (THDP-binding)
52922 - TK C-terminal domain-like | 0.07448 | Inherited |
64593,64593
64593 - Intermediate filament protein, coiled coil region
64593 - Intermediate filament protein, coiled coil region | 0.1594 | Inherited |
53901,53901
53901 - Thiolase-like
53901 - Thiolase-like | 0.1848 | Inherited |
63411,63411
63411 - LuxS/MPP-like metallohydrolase
63411 - LuxS/MPP-like metallohydrolase | 0.224 | Inherited |
52833,47616
52833 - Thioredoxin-like
47616 - GST C-terminal domain-like | 0.6753 | Inherited |
54849,52029
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.7145 | Inherited |
57440,57440
57440 - Kringle-like
57440 - Kringle-like | 0.7145 | Inherited |
54452,48726
54452 - MHC antigen-recognition domain
48726 - Immunoglobulin | 0.7268 | Inherited |
48592,54849
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like | 0.7606 | Inherited |
47986,52129
47986 - DEATH domain
52129 - Caspase-like | 0.9084 | Inherited |
47986,47986
47986 - DEATH domain
47986 - DEATH domain | 0.9528 | Inherited |
56112,56112
56112 - Protein kinase-like (PK-like)
56112 - Protein kinase-like (PK-like) | 0.9528 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Jump to [ Top · Hierarchy ]
Supra-domain (Triple) in N- to C-terminal order( show details)
Highlighted in gray are those with FDR>0.001
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
46966,51045,47473
46966 - Spectrin repeat
51045 - WW domain
47473 - EF-hand | 0 | DIRECT |
49899,48726,49265
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin
49265 - Fibronectin type III | 0 | DIRECT |
57184,100895,48726
57184 - Growth factor receptor domain
100895 - Kazal-type serine protease inhibitors
48726 - Immunoglobulin | 0 | DIRECT |
57196,57535,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain
57535 - Complement control module/SCR domain | 0 | DIRECT |
49562,57889,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain
57889 - Cysteine-rich domain | 0 | DIRECT |
46966,46966,51045
46966 - Spectrin repeat
46966 - Spectrin repeat
51045 - WW domain | 0 | DIRECT |
51045,47473,47473
51045 - WW domain
47473 - EF-hand
47473 - EF-hand | 0 | DIRECT |
47986,47986,52129
47986 - DEATH domain
47986 - DEATH domain
52129 - Caspase-like | 0 | DIRECT |
57196,57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0000691 | DIRECT |
69179,69179,69179
69179 - Integrin domains
69179 - Integrin domains
69179 - Integrin domains | 0.0001383 | DIRECT |
69318,69179,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains
69179 - Integrin domains | 0.0001599 | DIRECT |
57196,57196,57184
57196 - EGF/Laminin
57196 - EGF/Laminin
57184 - Growth factor receptor domain | 0.0004215 | DIRECT |
46966,46966,46966
46966 - Spectrin repeat
46966 - Spectrin repeat
46966 - Spectrin repeat | 0.002209 | INHERITED FROM: Tretinoin || Vitamin A |
49899,49899,49899
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases | 0.002438 | INHERITED FROM: Tretinoin || Vitamin A |
57440,57440,57440
57440 - Kringle-like
57440 - Kringle-like
57440 - Kringle-like | 0.224 | INHERITED FROM: Isotretinoin |
48592,54849,52029
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.7606 | INHERITED FROM: CD 437 |
| Supra-domain (Triple) in N- to C-terminal order |
FDR (all) |
Annotation (direct or inherited) |
46966,51045,47473
46966 - Spectrin repeat
51045 - WW domain
47473 - EF-hand | 0 | Direct |
49899,48726,49265
49899 - Concanavalin A-like lectins/glucanases
48726 - Immunoglobulin
49265 - Fibronectin type III | 0 | Direct |
57184,100895,48726
57184 - Growth factor receptor domain
100895 - Kazal-type serine protease inhibitors
48726 - Immunoglobulin | 0 | Direct |
57196,57535,57535
57196 - EGF/Laminin
57535 - Complement control module/SCR domain
57535 - Complement control module/SCR domain | 0 | Direct |
49562,57889,57889
49562 - C2 domain (Calcium/lipid-binding domain, CaLB)
57889 - Cysteine-rich domain
57889 - Cysteine-rich domain | 0 | Direct |
46966,46966,51045
46966 - Spectrin repeat
46966 - Spectrin repeat
51045 - WW domain | 0 | Direct |
51045,47473,47473
51045 - WW domain
47473 - EF-hand
47473 - EF-hand | 0 | Direct |
47986,47986,52129
47986 - DEATH domain
47986 - DEATH domain
52129 - Caspase-like | 0 | Direct |
57196,57196,57196
57196 - EGF/Laminin
57196 - EGF/Laminin
57196 - EGF/Laminin | 0.0000691 | Direct |
69179,69179,69179
69179 - Integrin domains
69179 - Integrin domains
69179 - Integrin domains | 0.0001383 | Direct |
69318,69179,69179
69318 - Integrin alpha N-terminal domain
69179 - Integrin domains
69179 - Integrin domains | 0.0001599 | Direct |
57196,57196,57184
57196 - EGF/Laminin
57196 - EGF/Laminin
57184 - Growth factor receptor domain | 0.0004215 | Direct |
46966,46966,46966
46966 - Spectrin repeat
46966 - Spectrin repeat
46966 - Spectrin repeat | 0.002209 | Inherited |
49899,49899,49899
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases
49899 - Concanavalin A-like lectins/glucanases | 0.002438 | Inherited |
57440,57440,57440
57440 - Kringle-like
57440 - Kringle-like
57440 - Kringle-like | 0.224 | Inherited |
48592,54849,52029
48592 - GroEL equatorial domain-like
54849 - GroEL-intermediate domain like
52029 - GroEL apical domain-like | 0.7606 | Inherited |
LINKTO: Supra-domain2BO Download and Supra-domain2BO Algorithm
Plot distribution on species Tree Of Life (sTOL) for Superfamily and/or Family domains annotated by this CC term
 |
Plot tree as:
| |
Download Newick format tree:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domain
architecture data for all genomes in SUPERFAMILY. The PAUP
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
Plot distribution on species Tree Of Life (sTOL) for single supra-domains annotated by this CC term
|
Plot tree as:
| |
Download Newick format tree:
| |
Browsing in TREE OF LIFE:
|
( show help)
Trees by TreeVector
A presence/absence matrix is generated using protein domains and supradomains
for all genomes in SUPERFAMILY. The RAxML
software is used to produce a single, large tree topology using
heuristic parsimony methods. Genome combinations, or specific clades, can be displayed as
if individual trees had been produced. However, this data is extracted from the single
large tree. This produces a higher quality topology than if the trees had been produced
on their own, and allows the trees to be displayed instantly.
|
|
> BO Hierarchy > Cyclohexenes
